Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

S-6472

Known as: S 6472, S6472 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
For an objective evaluation of the clinical efficacy, safety and usefulness of S 6472 (a long acting cefaclor) in non… Expand
Is this relevant?
1986
1986
The S6472 is a 4:6 mixture of 2 types of granules of cefaclor (CCL) coated with different films; one type of granules is soluble… Expand
Is this relevant?
1986
1986
S6472 is a mixture of cefaclor (CCL) granules with gastric-soluble coating and those with enteric-soluble coating at the ratio… Expand
Is this relevant?
1985
1985
To objectively evaluated the usefulness of the standard formulation of cefaclor (CCL) and the long-acting formulation of cefaclor… Expand
Is this relevant?
1985
1985
In order to see absorption and excretion of S6472 (sustained release preparations of cefaclor (CCL], 3 studies regarding, 1… Expand
Is this relevant?
1985
1985
Fundamental and clinical studies on S6472, a new prolonged acting preparation of cefaclor, were performed and the following… Expand
Is this relevant?
1985
1985
Current (regular) preparation of cefaclor (CCL) require the 3-time-a-day administration. S6472 (sustained release preparation… Expand
Is this relevant?
1985
1985
A study in which 375 mg of S6472 was orally given to 3 healthy adult volunteers before a meal, after a light meal, and after a… Expand
Is this relevant?
1985
1985
This study was conducted to develop a prolonged action preparation of cefaclor (CCL) which can offer, with the twice-a-day… Expand
Is this relevant?